Edgewise Therapeutics Financial Overview
Edgewise Therapeutics's market cap is currently $2.49B. The company's EPS TTM is $-0.39; its P/E ratio is ―; Edgewise Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
